Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction

NCT03414970 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.

NCT NCT03414970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03414970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
Lead sponsor
Alliance for Clinical Trials in Oncology
Phase
Phase 3
Overall status
Active, not recruiting
Start date
March 12, 2018
Completion date
August 31, 2035
Enrollment
898 (actual)
Sites
859

Conditions

As the registry lists them; a condition with its own page is linked.

ductal breast carcinoma, invasive breast carcinoma, lobular breast carcinoma, medullary breast carcinoma, stage ii breast cancer, stage iia breast cancer, stage iib breast cancer, stage iiia breast cancer, tubular breast carcinoma